Results 181 to 190 of about 121,181 (280)

Herbal formulas and gastrointestinal motility: Bridging traditional medicine and mechanistic insights. [PDF]

World J Gastroenterol
Zalzman M, Banerjee A.
europepmc   +1 more source

Weekly Subcutaneous VK2735, a GIP/GLP‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study

Obesity, Volume 34, Issue 3, Page 537-549, March 2026.
Four doses of VK2735 and a placebo group were included in the VENTURE study. Adults who were overweight or had obesity had significant weight loss when taking any dose of VK2735 for 13 weeks. More people lost at least 10% of their body weight as the dose increased.
Harold E. Bays, Phillip Toth, Naim Alkhouri, John Pullman, Bradley Freilich, Joel Neutel, Summer Ji, Scott Stubbe, Parke Hedges, Brian Lian   +9 more
wiley   +1 more source

FATIGUE DYSPEPSIA [PDF]

BMJ, 1915
openaire   +2 more sources

Muscle Dysfunction and Bone Loss in a Woman With Cystic Fibrosis and Obesity Treated With Glucagon‐Like Peptide 1 Agonist: A Case Report

Respirology Case Reports, Volume 14, Issue 3, March 2026.
Cystic fibrosis (CF) modulator therapies can lead to rapid and excessive weight gain. Obesity in CF can lead to undesirable metabolic complications including type 2 diabetes. Therefore, glucagon‐like peptide 1 (GLP‐1) agonists which can facilitate weight loss and improve metabolic profiles are increasingly prescribed to people with CF.
Shanal Kumar, Robyn Cobb, Angela Matson, Joseph Lee, Daniel Henderson   +4 more
wiley   +1 more source

Bloating, Visible Abdominal Distension, and Other Intestinal Gas-Related Symptoms in Irritable Bowel Syndrome and Functional Dyspepsia. [PDF]

United European Gastroenterol J
van Gils T, Katsumata R, Hreinsson JP, Drossman DA, Tack J, Törnblom H, Le Nevé B, Quinquis L, Hassouna R, Schmulson MJ, Bangdiwala SI, Palsson OS, Simrén M.   +12 more
europepmc   +1 more source

Paired Duodenal and Salivary Microbiome Analysis in Pancreatic Cancer Without Duct Obstruction

United European Gastroenterology Journal, Volume 14, Issue 2, March 2026.
ABSTRACT Background Bacterial migration from the oral cavity to the upper gastrointestinal tract has been proposed as a contributor to pancreatic ductal adenocarcinoma (PDAC) onset and prognosis. Whether PDAC is associated with alterations of the oral–duodenal microbiome continuum remains unclear.
Livia Archibugi, Loris Bertoldi, Giuseppe Benvenuto, Eleonora Sattin, Ruggero Ponz De Leon Pisani, Claudia Fortunato, Alberto Mariani, Gemma Rossi, Maria Chiara Petrone, Giorgio Valle, Michele Reni, Massimo Falconi, Paolo Giorgio Arcidiacono, Gabriele Capurso   +13 more
wiley   +1 more source

Efficacy and safety of acupuncture for functional dyspepsia: an updated meta-analysis of randomized controlled trials. [PDF]

Front Med (Lausanne)
Li XX, Hu ZY, Li ZC, Tang J, Liu YY, Zeng DH, Zhou QQ, Ma WB, Lan L, Wang L.   +9 more
europepmc   +1 more source

EUROHELICAN—The First Helicobacter Pylori Screen‐and‐Treat Population‐Based Study in Young Adults in Europe

United European Gastroenterology Journal, Volume 14, Issue 2, March 2026.
ABSTRACT Background Most gastric cancer cases are attributable to chronic Helicobacter pylori (H. pylori) infection and can theoretically be prevented. Objective In the EUROHELICAN project, we aimed to assess the feasibility, acceptability, effectiveness, and adverse events of a Helicobacter pylori screen‐and‐treat program in the 30–34‐year age group ...
Bojan Tepeš, Tatjana Kofol Bric, Jernej Završnik, Mitja Oblak, Marcel Kralj, Alja Polajžer, Helena Blažun Vošner, Nataša Maguša Lorber, Jin Young Park, Tamara Matysiak‐Budnik   +9 more
wiley   +1 more source

Large Language Model‐Driven Analysis and Report Generation of Endoscopy Videos—A Pilot Study

Digestive Endoscopy, Volume 38, Issue 3, March 2026.
ABSTRACT Multimodal large language models (MLLMs) can automatically analyze clinical video, but evidence from full esophagogastroduodenoscopy (EGD) and the impact of on‐screen computer‐aided detection/diagnosis (CAD) overlays on MLLM behavior remain unclear. We tested whether an MLLM can produce clinically adequate EGD reports and whether a CAD overlay
Davide Massimi, Luca Di Stefano, Tommy Rizkala, Marco Spadaccini, Yuichi Mori, Maddalena Menini, Giulio Antonelli, Kareem Khalaf, Raf Bisschops, Daniel von Renteln, Prateek Sharma, Douglas K. Rex, Michael Bretthauer, Carlo Castoro, LLM Working Group, Roberto De Sire, Ludovico Alfarone, Alessandro D’Aprano, Silvia Carrara, Roberta Maselli, Vincenzo Vadalà, Francesco Menini, Abdelrahman Ashraf Alawdy Elsaman, Alessandro Fugazza, Matteo Colombo, Renato de Martino, Antonio Capogreco, Gianluca Franchelucci, Victor Savevski, Elena De Momi, Luca Carlini, Chiara Lena, Sravanthi Parasa, Susanne O’Reilly, Simone Dibitetto, Matteo Spertino, Alessandro Repici, Cesare Hassan   +37 more
wiley   +1 more source

Efficacy and safety of CT‐868, a novel, fully biased, dual glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double‐blind, randomized placebo controlled phase 2 trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1673-1682, March 2026.
Abstract Aims To assess the glycaemic efficacy and safety of CT‐868, a cAMP signal‐biased, dual glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide receptor agonist, in participants with type 2 diabetes (T2D). Materials and Methods This 26‐week (W), phase 2, randomized, double‐blind placebo‐controlled trial enrolled adults with T2D ...
Manu V. Chakravarthy, Michael A. Elliott, Luis Acosta, Gabriele E. Sonnenberg, Damian Bialonczyk, Jingtao Wu, Federico A. Argüelles‐Tello, Raymundo Garcia‐Reza, José Gerardo González‐González, Stig K. Hansen, Juan P. Frias   +10 more
wiley   +1 more source